LiverTox: Clinical et al., 2021-04-09: The U.S. federal drug-induced-liver-injury reference entry for ivermectin, scoring it a likelihood D: a possible but rare cause of mild, self-limited liver injury. It records one published case and notes that aminotransferase elevations in COVID-19 trials were no more frequent on ivermectin than on placebo or comparator.
Ivermectin has not been associated with acute liver failure or chronic liver injury.
LiverTox: Clinical et al., 2021-04-09: The U.S. federal drug-induced-liver-injury reference entry for ivermectin, scoring it a likelihood D: a possible but rare cause of mild, self-limited liver injury. It records one published case and notes that aminotransferase elevations in COVID-19 trials were no more frequent on ivermectin than on placebo or comparator. Study type: review.
